The Hemojuvelin-Hepcidin Axis as a Target for the Treatment of Anemia or Conversely Polycythemia. Gangat N, Tefferi A. Am J Hematol 2025 Oct 21. doi: 10.1002/ajh.70120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gangat N, Tefferi A. The Hemojuvelin-Hepcidin Axis as a Target for the Treatment of Anemia or Conversely Polycythemia. Am J Hematol 2025 Oct 21. doi: 10.1002/ajh.70120.
PMID: 41117748